HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exploring high pressure nebulization of Pluronic F127 hydrogels for intraperitoneal drug delivery.

Abstract
Peritoneal metastasis is an advanced cancer type which can be treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Here, chemotherapeutics are nebulized under high pressure in the intraperitoneal (IP) cavity to obtain a better biodistribution and tumor penetration. To prevent the fast leakage of chemotherapeutics from the IP cavity, however, nebulization of controlled release formulations is of interest. In this study, the potential of the thermosensitive hydrogel Pluronic F127 to be applied by high pressure nebulization is evaluated. Therefore, aerosol formation is experimentally examined by laser diffraction and theoretically simulated by computational fluid dynamics (CFD) modelling. Furthermore, Pluronic F127 hydrogels are subjected to rheological characterization after which the release of fluorescent model nanoparticles from the hydrogels is determined. A delicate equilibrium is observed between controlled release properties and suitability for aerosolization, where denser hydrogels (20% and 25% w/v Pluronic F127) are able to sustain nanoparticle release up to 30 h, but cannot effectively be nebulized and vice versa. This is demonstrated by a growing aerosol droplet size and exponentially decreasing aerosol cone angle when Pluronic F127 concentration and viscosity increase. Novel nozzle designs or alternative controlled release formulations could move intraperitoneal drug delivery by high pressure nebulization forward.
AuthorsHelena Braet, Mohammad Rahimi-Gorji, Charlotte Debbaut, Ghader Ghorbaniasl, Thibault Van Walleghem, Senne Cornelis, Sarah Cosyns, Chris Vervaet, Wouter Willaert, Wim Ceelen, Stefaan C De Smedt, Katrien Remaut
JournalEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V (Eur J Pharm Biopharm) Vol. 169 Pg. 134-143 (Dec 2021) ISSN: 1873-3441 [Electronic] Netherlands
PMID34634467 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Elsevier B.V. All rights reserved.
Chemical References
  • Aerosolized Particles and Droplets
  • Antineoplastic Agents
  • Delayed-Action Preparations
  • Excipients
  • Hydrogels
  • Poloxamer
Topics
  • Aerosolized Particles and Droplets (pharmacology)
  • Antineoplastic Agents (pharmacology)
  • Delayed-Action Preparations (pharmacology)
  • Drug Compounding (methods)
  • Excipients (pharmacology)
  • Humans
  • Hydrodynamics
  • Hydrogels (pharmacology)
  • Nanoparticles (therapeutic use)
  • Nebulizers and Vaporizers
  • Peritoneal Absorption (drug effects)
  • Peritoneal Neoplasms (secondary, therapy)
  • Poloxamer (pharmacology)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: